Simple jQuery Dropdowns

Browsing by Author Mauro Orlando

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)
1-Jan-2015Epidermal growth factor receptor mutation status in the treatment of non-small cell lung cancer: Lessons learnedDae Ho Lee; Vichien Srimuninnimit; Rebecca Cheng; Xin Wang; Mauro Orlando; Asan Medical Center; Mahidol University; Eli Lilly and Company; Eli Lilly Interamerica Inc.
1-Mar-2016First-Line Pemetrexed Plus Cisplatin Followed by Gefitinib Maintenance Therapy Versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non-Small-cell Lung Cancer: Quality of Life Results from a Randomized Phase III TrialMark Boye; Xin Wang; Vichien Srimuninnimit; Jin Hyoung Kang; Chun Ming Tsai; Mauro Orlando; Tarun Puri; Jong Seok Kim; Narayan Rajan; James Chih Hsin Yang; Eli Lilly and Company; Mahidol University; The Catholic University of Korea; National Yang-Ming University Taiwan; Eli Lilly Interamerica Inc.; Eli Lilly Australia Pty Ltd.; National Taiwan University Hospital
1-Jan-2014First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: A randomised, phase 3 trialJames Chih Hsin Yang; Jin Hyoung Kang; Tony Mok; Myung Ju Ahn; Vichien Srimuninnimit; Chia Chi Lin; Dong Wan Kim; Chun Ming Tsai; Helen Barraclough; Sedat Altug; Mauro Orlando; Keunchil Park; National Taiwan University Hospital; The Catholic University of Korea; Chinese University of Hong Kong; SungKyunKwan University, School of Medicine; Mahidol University; Seoul National University Hospital; Veterans General Hospital-Taipei; Eli Lilly and Company